Correlation Between Genscript Biotech and Arcellx
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Arcellx, you can compare the effects of market volatilities on Genscript Biotech and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Arcellx.
Diversification Opportunities for Genscript Biotech and Arcellx
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genscript and Arcellx is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Arcellx go up and down completely randomly.
Pair Corralation between Genscript Biotech and Arcellx
Assuming the 90 days horizon Genscript Biotech is expected to under-perform the Arcellx. But the pink sheet apears to be less risky and, when comparing its historical volatility, Genscript Biotech is 1.15 times less risky than Arcellx. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Arcellx is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 8,499 in Arcellx on August 29, 2024 and sell it today you would earn a total of 597.00 from holding Arcellx or generate 7.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genscript Biotech vs. Arcellx
Performance |
| Timeline |
| Genscript Biotech |
| Arcellx |
Genscript Biotech and Arcellx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Arcellx
The main advantage of trading using opposite Genscript Biotech and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |